In vitro and in silico studies on cell adhesion protein peroxinectin from Fenneropenaeus indicus and screening of

Jeyachandran Sivakamavalli1, Chandrabose Selvaraj2, Sanjeev Kumar Singh2

  • 1Crustacean Molecular Biology and Genomics Lab, Department of Animal Health and Management, Alagappa University, Karaikudi, 630 004, , Tamil Nadu, India.

Insights

This study investigates peroxinectin (PX) in shrimp immunity. Researchers identified PX as a key regulator of the prophenoloxidase (proPO) pathway, crucial for antioxidant defense against pathogens.

Area of Science:

  • Immunology
  • Biochemistry
  • Marine Biology

Background:

  • The prophenoloxidase (proPO) pathway is vital for invertebrate immune responses against pathogens.
  • Peroxinectin (PX) plays a critical role in regulating proPO activity and preventing self-damage from excessive antioxidant production.
  • PX is a key target for understanding immune regulation in crustaceans.

Purpose of the Study:

  • To characterize the Indian white shrimp Fenneropenaeus indicus peroxinectin (Fein-PX) gene.
  • To investigate the upregulation of Fein-PX expression using immunostimulants.
  • To identify potential inhibitors for negative regulation of Fein-PX.

Main Methods:

  • Gene sequencing of Fenneropenaeus indicus PX (Fein-PX).
  • Quantitative RT-PCR to examine Fein-PX expression levels.
  • Screening of inhibitors for Fein-PX and 3D modeling for rational drug design.

Main Results:

  • The Fein-PX gene sequence was successfully obtained and analyzed.
  • Immunostimulant β-glucan upregulated Fein-PX expression, confirming its role in immune activation.
  • Inhibitor screening and 3D modeling provided insights for designing molecules targeting Fein-PX.

Conclusions:

  • Fein-PX is a crucial component in the shrimp proPO pathway, involved in immune regulation.
  • Understanding Fein-PX regulation can lead to novel strategies for enhancing shrimp immunity.
  • Targeting Fein-PX offers potential for developing new therapeutic agents against shrimp diseases.